Recombinant cobra venom factor

Molecular Immunology

Volumn 41, Issue 2-3, 2004, Pages 191-199

  Vogel, Carl Wilhelm ^a   Fritzinger, David C ^a   Hew, Brian E ^a   Thorne, Mike ^a   Bammert, Holger ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Cobra venom factor (CVF); Complement depletion; Pro cobra venom factor (Pro CVF); Recombinant protein expression

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COBROTOXIN; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C5; MAGNESIUM ION; PROTEIN; PROTEIN FACTOR D; RECOMBINANT COBROTOXIN; SNAKE VENOM; UNCLASSIFIED DRUG;

BACULOVIRUS; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONFERENCE PAPER; DROSOPHILA MELANOGASTER; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVATION; EUKARYOTE; EXPERIMENT; EXPERIMENTAL ANIMAL; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; HOST RESISTANCE; IMMUNE RESPONSE; INHIBITION KINETICS; INSECT CELL; LEPIDOPTERA; MOLECULAR CLONING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROKARYOSIS; PROKARYOTE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SERUM; SNAKE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TECHNIQUE; VIRUS INFECTION;

ANIMALS; CLONING, MOLECULAR; COBRA VENOMS; COMPLEMENT ACTIVATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS;

ANIMALIA; DROSOPHILA MELANOGASTER; ELAPIDAE; EUKARYOTA; INSECTA; MELANOGASTER; NAJA; PROKARYOTA; SPODOPTERA; SPODOPTERA FRUGIPERDA; UNIDENTIFIED BACULOVIRUS;

EID: 2442686871     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.03.011     Document Type: Conference Paper

References (36)

1. Alper C.A., Balavitch D. Cobra venom factor: Evidence for its being altered cobra C3 (the third component of complement). Science. 191:1976;1275-1276
2. Bambai B., Teppke M., Bredehorst R., Vogel C.-W. cDNA cloning and expression of cobrin, the C3-cleaving metalloprotease from cobra venom. Mol. Immunol. 35:1998;408
3. Cochrane C.G., Müller-Eberhard H.J., Aikin B.S. Depletion of plasma complement in vivo by a protein of cobra venom: Its effect on various immunologic reactions. J. Immunol. 105:1970;55-69
4. Daha M.R., Fearon D.T., Austen K.F. C3 requirements for formation of alternative pathway C5 convertase. J. Immunol. 117:1976;630-634
5. Fritzinger D.C., Bredehorst R., Vogel C.-W. Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. USA. 91:1994;12775-12779
6. Fritzinger D.C., Hew B.E., Wehrhahn D., Vogel C.-W. Functional characterization of cobra venom factor/cobra C3 hybrid proteins. Mol. Immunol. 40:2003;199
7. x structures. Glycobiology. 11:2001;195-208
8. Gowda D.C., Petrella E.C., Raj T.T., Bredehorst R., Vogel C.-W. Immunoreactivity and function of oligosaccharides in cobra venom factor. J. Immunol. 152:1994;2977-2986
9. Hensley P., O'Keefe M.C., Spangler C.J., Osborne J.C. Jr., Vogel C.-W. The effects of metal ions and temperature on the interaction of cobra venom factor and human complement factor B. J. Biol. Chem. 261:1986;11038-11044
10. Hew, B.E., Thorne, M., Fritzinger, D.C., Vogel, C.-W., 2004. Humanized cobra venom factor (CVF): Generation of human C3 derivatives with CVF-like function. Mol. Immunol. 41 (2-3).
11. Isenman D.E., Podack E.R., Cooper N.R. The interaction of C5 with C3b in free solution: A sufficient condition for cleavage by a fluid phase C3/C5 convertase. J. Immunol. 124:1980;326-331
12. Kock, M.A., 1996. Expression and characterization of recombinant cobra venom factor. Dissertation, University of Hamburg, Hamburg, Germany.
13. Kock M.A., Ziegelmüller P., Bredehorst R., Vogel C.-W. Recombinant expression of active cobra venom factor (CVF). Mol. Immunol. 33:1996;15
14. Lachmann P.J., Halbwachs L. The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin. Exp. Immunol. 21:1975;109-114
15. Medicus R.G., Götze O., Müller-Eberhard H.J. Alternative pathway of complement: Recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J. Exp. Med. 144:1976;1076-1093
16. Morgan B.P., Harris C.L. Complement therapeutics history and current progress. Mol. Immunol. 40:2003;159-170
17. Nagaki K., Iida K., Okubo M., Inai S. Reaction mechanisms of beta1H globulin. Int. Arch. Allergy Appl. Immunol. 57:1978;221-232
18. O'Keefe M.C., Caporale L.H., Vogel C.-W. A novel cleavage product of human complement component C3 with structural and functional properties of cobra venom factor. J. Biol. Chem. 263:1988;12690-12697
19. Pangburn M.K., Müller-Eberhard H.J. The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase. Biochem. J. 235:1986;723-730
20. Pangburn M.K., Schreiber R.D., Müller-Eberhard H.J. Human complement C3b inactivator: Isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146:1977;257-270
21. Petrella E.C., O'Keefe M.C., Bredehorst R., Vogel C.-W. Purification and characterization of two C3-cleaving proteases from cobra venom. Complement Inflamm. 9:1991;210
22. Smith C.A., Vogel C.-W., Müller-Eberhard H.J. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. J. Biol. Chem. 257:1982;9879-9882
23. Smith C.A., Vogel C.-W., Müller-Eberhard H.J. MHC class III products: An electron microscopic study of the C3 convertases of human complement. J. Exp. Med. 159:1984;324-329
24. Vogel, C.-W., 1987. Antibody conjugates without inherent toxicity: The targeting of cobra venom factor and other biological response modifiers. In: Vogel, C.-W. (Ed.), Immunoconjugates. Antibody conjugates in radioimaging and therapy of cancer. Oxford University Press, New York, pp. 170-188.
25. Vogel, C.-W., 1991. Cobra venom factor, the complement-activating protein of cobra venom. In: Tu, A. T. (Ed.), Handbook of natural toxins: Reptile and amphibian venoms, Vol. 5. Marcel Dekker, New York, pp. 147-188.
26. Vogel C.-W., Bredehorst R., Fritzinger D.C., Grunwald T., Ziegelmüller P., Kock M.A. Structure and function of cobra venom factor, the complement-activating protein in cobra venom. Adv. Exp. Med. Biol. 391:1996;97-114
27. Vogel C.-W., Müller-Eberhard H.J. Induction of immune cytolysis: Tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertase. Proc. Natl. Acad. Sci. USA. 78:1981;7707-7711
28. Vogel C.-W., Müller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 257:1982;8292-8299
29. Vogel C.-W., Müller-Eberhard H.J. Cobra venom factor: Improved method for purification and biochemical characterization. J. Immunol. Meth. 73:1984;203-220
30. Vogel C.-W., Smith C.A., Müller-Eberhard H.J. Cobra venom factor: Structural homology with the third component of human complement. J. Immunol. 133:1984;3235-3241
31. Vogt W., Dieminger L., Lynen R., Schmidt G. Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe-Seyler's Z. Physiol. Chem. 355:1974;171-183
32. Vogt W., Schmidt G. Hydrolytic activation of the fifth component of complement (C5) by C3 convertases depends on its binding to surface-fixed C3b: Specific interference with binding, by properdin, factor B, or propamidine, leads to inhibition of C5 cleavage and utilization. J. Immunol. 120:1978;1801
33. Vogt W., Schmidt G., von Buttlar B. Factors and conditions essential for the activation of the fifth component of complement and release of anaphylatoxin. Monogr. Allergy. 12:1977;86-89
34. von Zabern I., Hinsch B., Przyklenk H., Schmidt G., Vogt W. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: Correlation between binding affinity for the fifth component of complement and mediation of its cleavage. Immunobiology. 157:1980;499-514
35. Wehrhahn D., Meiling K., Fritzinger D.C., Bredehorst R., Andrä J., Vogel C.-W. Analysis of the structure/function relationship of cobra venom factor (CVF) and C3: Generation of CVF/cobra C3 hybrid proteins. Immunopharmacology. 49:2000;94
36. Whaley K., Ruddy S. Modulation of the alternative complement pathways by beta1H globulin. J. Exp. Med. 144:1976;1147-1163